These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors]. Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998 [TBL] [Abstract][Full Text] [Related]
7. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003]. Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676 [TBL] [Abstract][Full Text] [Related]
8. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998 [TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients. Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924 [TBL] [Abstract][Full Text] [Related]
11. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis]. Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511 [No Abstract] [Full Text] [Related]
12. Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer. Neyer M; Peschel R; Akkad T; Springer-Stöhr B; Berger A; Bartsch G; Steiner H J Endourol; 2007 Feb; 21(2):180-3. PubMed ID: 17338618 [TBL] [Abstract][Full Text] [Related]
13. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis. Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573 [TBL] [Abstract][Full Text] [Related]